Journal of Pharmaceutical Health Services Research最新文献

{"title":"Evaluation of a structured pharmacist-led intervention on glycemic control in underprivileged diabetic patients: a randomized open-label trial","authors":"Maha Abdul-Latif, R. Nagib, Mohamed E K Amin, A. El-Yazbi","doi":"10.1093/jphsr/rmae017","DOIUrl":"https://doi.org/10.1093/jphsr/rmae017","url":null,"abstract":"\u0000 \u0000 \u0000 This study assesses the impact of a structured clinical pharmacist intervention on glycemic control in diabetic patients maintained on intensive insulin therapy attending the internal medicine clinic in a hospital with limited financial resources.\u0000 \u0000 \u0000 \u0000 A randomized parallel open-label clinical trial design was employed. Ethical approval was obtained from the Egyptian Ministry of Health (MOH) ethics committee. Adult diabetic patients, on intensive insulin therapy, were recruited from an internal medicine clinic at an MOH hospital. Patients were randomly allocated into two groups; control, on premixed insulin twice daily, and intervention, receiving a structured pharmacist intervention including the addition of regular insulin doses as needed. Patients were followed up for three months. A 1% reduction of HbA1c level at the conclusion was considered the primary outcome.\u0000 \u0000 \u0000 \u0000 One hundred and twenty-five patients (62 control and 63 intervention) consented to participate in the study, of whom 98 (46 control and 52 intervention) completed the follow-up period. At three months, the odds ratio for HbA1c reduction by at least by 1% in the intervention group was 3.2 (95% CI 1.45–7.08). Very few cases of hypoglycemia were reported in either group. The HbA1c reduction was not affected by age, weight, or literacy status of the patients.\u0000 \u0000 \u0000 \u0000 Clinical pharmacist interventions, even in environments with scarce resources and socioeconomic challenges, remain effective in achieving better glycemic control. This trial has been registered in the Pan-African Clinical Trial Registry (PACTR201610001812290, https://pactr.samrc.ac.za/).\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141819816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The revised patient attitudes to deprescribing (rPATD) questionnaire: an investigation using a large anonymized database","authors":"Marjorie Weiss, Rhian Deslandes, Louise Hughes","doi":"10.1093/jphsr/rmae014","DOIUrl":"https://doi.org/10.1093/jphsr/rmae014","url":null,"abstract":"\u0000 \u0000 \u0000 Stopping or “deprescribing” one or more of a patient’s medications is a growing focus for clinical practice and health service research. A deprescribing questionnaire survey, the revised Patient’s Attitudes Towards Deprescribing (rPATD), has been developed and validated in Australia. The aim of this study was to explore the use of the rPATD in a large Welsh population.\u0000 \u0000 \u0000 \u0000 The rPATD was made available through HealthWise Wales, a platform that enables people in Wales to volunteer to participate in research. Questionnaire data were explored descriptively and using a confirmatory factor analysis (CFA) on the original four factors in the rPATD (Burden, Appropriateness, Concern, and Involvement).\u0000 \u0000 \u0000 \u0000 A total of 1759 patients completed questionnaires. The mean age was 58.6, each prescribed on average 3.69 medicines (range 1–34). In total 75.1% (1303/1735) agreed or strongly agreed that they would be willing to have a medicine deprescribed, if suggested by a doctor, and 19.0% (333/1749) would like to try stopping a medicine. A CFA was performed using maximum likelihood and showed a mediocre fit (RMSEA = 0.083). A Mann–Whitney U test revealed an association between feeling the burden of medicine taking or expressing a belief in the inappropriateness of their medication and a greater willingness to stop medicine if suggested by a doctor (BURDEN Z = −5.6, P≤.0001; appropriateness Z = −9.6, P≤.0001).\u0000 \u0000 \u0000 \u0000 Willingness to have a medicine deprescribed was lower than in previous research, likely due to a range of reported factors. The potential value of rPATD has been demonstrated for future UK-wide applications.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141818976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cross-sectional study of pharmacists’ knowledge and beliefs about human papillomavirus, its vaccines, and barriers related to vaccine administration","authors":"Linda Alyahya, Mariam Al-Ameri, R. A. Abu Farha, T. Mukattash, D. A. Mohamed Noor","doi":"10.1093/jphsr/rmae016","DOIUrl":"https://doi.org/10.1093/jphsr/rmae016","url":null,"abstract":"\u0000 \u0000 \u0000 The human papillomavirus (HPV) vaccine is not currently included in the national immunization program in Jordan. The rising prevalence of cervical cancer in Jordan highlights the necessity for a novel approach to boost HPV vaccination rates. Thus, the main objective of this study was to assess the knowledge, beliefs, and potential barriers concerning HPV and HPV vaccine administration in community pharmacies.\u0000 \u0000 \u0000 \u0000 This cross-sectional study, conducted in Jordan between July and September 2023, involved community pharmacists. Using a convenience sampling approach, one author visited various community pharmacies to distribute and collect questionnaires. A total knowledge score, out of a possible 10 points, and a belief score out of 40 were calculated for each pharmacists. Additionally, the study examined factors that may influence participants’ knowledge and belief levels.\u0000 \u0000 \u0000 \u0000 A total of 302 community pharmacists took part in the survey, with approximately two-thirds of the participants being female (n = 230, 76.2%). The average knowledge score about HPV was 2.7 out of 10 (standard deviation [SD] = 1.8), and linear regression analysis indicated no significant relationship between pharmacists’ knowledge about HPV and the factors studied, such as age, gender, area of pharmacy, and the acquired degree. In terms of beliefs, findings revealed that 63.2% supported an expanded role for community pharmacists in HPV vaccination. Three main barriers were identified: lack of parental knowledge (n = 218, 72.2%), insufficient educational materials for parents (n = 206, 68.2%), and inadequate provider knowledge (n = 201, 66.6%).\u0000 \u0000 \u0000 \u0000 In summary, this study provides valuable insights into the knowledge, beliefs, and challenges surrounding HPV and HPV vaccination among community pharmacists in Jordan. To enhance the involvement of community pharmacists in promoting HPV vaccination and aiding in the prevention of HPV-related illnesses, it is crucial to address the identified knowledge gaps and obstacles.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141830415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021","authors":"Heeyeon Lim, Minji Kim, Geeyoon Kang, Minji Ko, Eunyoung Kim","doi":"10.1093/jphsr/rmae012","DOIUrl":"https://doi.org/10.1093/jphsr/rmae012","url":null,"abstract":"\u0000 \u0000 \u0000 This cross-sectional study examines the Food and Drug Administration (FDA)’s Accelerated Approval (AA) pathway for cancer drugs from 1992 to 2021, which expedites the development and approval of new drugs, including biologics, for severe or life-threatening conditions such as cancers.\u0000 \u0000 \u0000 \u0000 Based on the ‘CDER Drug and Biologic AAs Based on a Surrogate Endpoint’ report, the number of indications where anticancer agents received AA and the conversion rates to Full Approval (FA) were analysed. Outcome measures used in phase II and phase III trials for these drugs were obtained from US National Library of Medicine for comparison.\u0000 \u0000 \u0000 \u0000 Of the 278 AA-granted indications, 67% were for anticancer agents. Lymphoma, leukemia, and lung cancer had the highest number of AA indications among all cancer types. The conversion rates to FA varied among periods: Early (1995–2003), Middle (2004–2012), and Late (2013–2021). The conversion rates for drugs were 82%, 79%, and 31%, while biologics exhibited rates of 100%, 78%, and 27%, respectively. The overall response rate was often the primary outcome measure in phase II trials, whereas overall survival and progression-free survival were the common outcome measures in phase III trials. Secondary outcome measures included disease control rate and duration of response.\u0000 \u0000 \u0000 \u0000 This study provides valuable insights for stakeholders seeking to understand the approval criteria and processes for cancer drugs via the AA pathway. However, limitations in data availability, phase-specific variations in drug doses and combinations, and the inability to manage uncertain data should be acknowledged. Research on the AA program to non-cancer drugs is also required.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141654634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Navigating digital health: perspectives of Australian community pharmacists—a short communication","authors":"Amina Hareem, I. Stupans, Joon Soo Park, Julie E. Stevens, Kate N Wang","doi":"10.1093/jphsr/rmae013","DOIUrl":"https://doi.org/10.1093/jphsr/rmae013","url":null,"abstract":"\u0000 \u0000 \u0000 This study explores the perspectives of Australian community pharmacists regarding digital health interventions, examining adoption rates, advantages, and barriers.\u0000 \u0000 \u0000 \u0000 A national voluntary online survey was conducted with Australian community pharmacists from September 2022 to June 2023.\u0000 \u0000 \u0000 \u0000 Of the 120 responses received, 118 were analysed. The main benefits identified included improved access to health records and patient care quality while major concerns included technical issues and data security. Suggestions for increased digital health adoption included digital health education and regulation.\u0000 \u0000 \u0000 \u0000 Australian community pharmacists play a crucial role in adopting digital health yet face significant challenges. Despite the potential of telehealth, community pharmacists have not widely embraced its adoption in their practice. The digital healthcare transformation necessitates collaborative efforts and strict guideline adherence for effective integration.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141703886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of COVID-19 on asthma and COPD patients’ hospital care: a lesson for future pandemics","authors":"O. Awwad, Suha A. Almuhaissen, Mariam Abdel Jalil, Zaina Battah, K. Abu Hammour, Saja Almonayer","doi":"10.1093/jphsr/rmae009","DOIUrl":"https://doi.org/10.1093/jphsr/rmae009","url":null,"abstract":"\u0000 \u0000 \u0000 Preventive measure for COVID-19 spread have dramatically affected patients with chronic diseases worldwide, including asthma/chronic obstructive pulmonary disease (COPD) patients. This study aimed to examine the impact of the COVID-19 outbreak and the associated lockdown on the medical care provision of asthma/COPD patients in Jordan. The healthcare behaviours and perceptions of these patients regarding the outbreak were also investigated.\u0000 \u0000 \u0000 \u0000 A population-based cohort study was conducted on asthma/COPD patients seeking medical care during 2019–2021 at a tertiary hospital in Jordan. Patients were interviewed by phone call, their medical files were also accessed. Demographics, clinical information, and those related to healthcare access (clinic visits, hospital admissions, and emergency room [ER] visits), exacerbation management and medication adherence were all collected.\u0000 \u0000 \u0000 \u0000 A total of 371 cases were identified, the majority (65.2%) were asthmatics. The most (76.3%) were not vaccinated (influenza or pneumococcal), none had a written action plan. The study findings showed reduced healthcare utilization (hospital admission and ER visits) during the study period (P < 0.05). Clinic visits also decreased over 2019–2020 (P < 0.05). Accordingly, the pattern of acute exacerbation treatment also changed with fewer antibiotics and inhaled corticosteroids administered during the pandemic (P < 0.05). Medication adherence was relatively low (14.6%–17.25%). Telemedicine was not provided during the study period.\u0000 \u0000 \u0000 \u0000 The study demonstrated disruption in healthcare utilization. There is need for better preparedness for future pandemics to maintain the routine medical care services. Telemedicine should be introduced as part of healthcare systems. Efforts are still needed to optimize medication adherence in Jordan. Future research is needed to better address COVID-19 impact on chronic patients.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140665659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring parental awareness and attitudes towards human papillomavirus infection and vaccination for 9–15-year-old adolescents in Jordan","authors":"Linda A Alyahya, R. A. Abu Farha, T. Mukattash, D. A. Mohamed Noor","doi":"10.1093/jphsr/rmae007","DOIUrl":"https://doi.org/10.1093/jphsr/rmae007","url":null,"abstract":"\u0000 \u0000 \u0000 This study aimed to analyze knowledge and beliefs regarding Human Papillomavirus (HPV) disease and its vaccine among the public, particularly parents of adolescents aged 9–15, who constitute the target group for the HPV vaccine, and to identify factors affecting their knowledge and beliefs.\u0000 \u0000 \u0000 \u0000 In Jordan, a cross-sectional study surveyed 386 parents of 9–15-year-olds. Data were collected through surveys to assess knowledge and attitudes about HPV and the HPV vaccine. Statistical analysis using SPSS provided insights.\u0000 \u0000 \u0000 \u0000 A total of 386 individuals participated in the survey. Approximately two-thirds were female (n = 245, 63.5%), and more than half of the participants were aged above 35 (n = 224, 58%). Concerning participants’ beliefs about HPV vaccines, around 19% believed that the efficacy of the HPV vaccine is unclear (n = 74, 19.2%), and only 35.5% trusted HPV vaccination (n = 137). Linear regression analysis revealed that female participants (mothers) and those with higher income (>1000 JD) tend to have better knowledge and belief scores compared to others (P < 0.05).\u0000 \u0000 \u0000 \u0000 In summary, this study highlights the pressing need for improved HPV education campaigns in Jordan. Heightening awareness of HPV and its associated health risks is paramount. The absence of the HPV vaccine in Arab national schedules exacerbates this awareness gap. Focusing on parents of adolescents is critical for vaccination efforts, and community pharmacies may aid in expanding vaccine coverage and awareness.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140729775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of increasing number of mental health conditions on healthcare costs and resource utilization among individuals with type 2 diabetes: a cross-sectional study","authors":"M. Bounthavong, Aysell Medina, Brooke M Wallace, Aryana Sepassi, C. Morello","doi":"10.1093/jphsr/rmae008","DOIUrl":"https://doi.org/10.1093/jphsr/rmae008","url":null,"abstract":"\u0000 \u0000 \u0000 To evaluate the association between the number of mental health conditions among individuals with type 2 diabetes (T2D) and healthcare expenditures in the USA.\u0000 \u0000 \u0000 \u0000 A cross-sectional study was conducted to evaluate the relationship between multiple mental health conditions (0, 1, and 2 or more mental health conditions) among individuals with T2D on healthcare expenditures using data from the 2019 US Medical Expenditure Panel Survey.\u0000 \u0000 \u0000 \u0000 A total of 24,091,931 weighted individuals with T2D were included for analysis; 76.8% had no co-occurring mental health conditions, 15.5% had one mental health condition, and 7.7% had two or more mental health conditions. Individuals with one and two or more mental health conditions had significantly greater total healthcare costs (+$7135 and +$7168), office-based costs (+$1196 and +$1483), prescription costs (+$2091 and +$3757), office-based visits (+3.55 and +6.46), and prescriptions fills (+13.97 and +26.77) than individuals with no mental health conditions.\u0000 \u0000 \u0000 \u0000 Individuals with T2D and an increasing number of co-occurring mental health conditions were associated with increased healthcare costs and resource utilization. Underlying mechanisms for this relationship remain unclear, and further investigations are needed to accurately assess the impact this may have on health outcomes.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140748229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist-led intervention to improve treatment outcomes in type 2 diabetes: a randomized controlled trial","authors":"M. Ihekoronye, K. Osemene, T. Oamen","doi":"10.1093/jphsr/rmae005","DOIUrl":"https://doi.org/10.1093/jphsr/rmae005","url":null,"abstract":"\u0000 \u0000 \u0000 Pharmacists’ contribution to medication therapy management in type 2 diabetes (T2D) is under-reported in Nigeria. This study evaluated the effectiveness of a pharmacy-based intervention on knowledge, pharmacy refills, medication adherence, and glycemic control among patients with T2D.\u0000 \u0000 \u0000 \u0000 A two-arm prospective, randomized, controlled trial among 309 T2D patients over 25 weeks duration was conducted in a tertiary hospital. The intervention group (n = 155) received weekly health education and follow-up sent as phone-based short message service (SMS), alongside standard care. Control group (n = 154) received only standard care. Primary (HbA1c reduction) and secondary (refill adherence, knowledge, and medication adherence) outcomes were assessed and compared in both groups at baseline and endline.\u0000 \u0000 \u0000 \u0000 Intervention improved glycemic control (HbA1c reduction) directly (t = 8.253, P < .001) and indirectly through improved pharmacy refill adherence as 115 (76%) of the intervention group were refill adherent (Proportion of Days Covered [PDC] > 80%). For controls, mean baseline and endline knowledge scores were 2.798 and 2.816, respectively (t = 1.19092, P > .005), while the intervention group had 2.732 and 4.462, respectively (t = 9.76157, P < .005) on a 5-point Likert scale. Baseline and endline adherence scores for control group were 3.41 and 3.50, respectively (t = 0.92477, P > .05), while the intervention group had 3.35 and 6.72, respectively (t = 17.87981, P < .05) on the 8-point Morisky Medication Adherence Scale (MMAS-8).\u0000 \u0000 \u0000 \u0000 Pharmacist-led intervention significantly improved medication refills, glycemic control, knowledge, and medication adherence. Pharmacists should exploit mobile telephony for health education and follow-up services to improve treatment outcomes in medication therapy management of T2D.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140382870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of burnout on over-the-counter counseling: a survey of community pharmacists in Vietnam","authors":"Van De Tran, Trung Tin Pham, Trung Hieu Le, Thanh Thao Nguyen Thi, Minh Trung Nguyen, Duong Phuc Phan, Thi Bich Thuy Bui, Cuong Minh Nguyen, R. S. Dewey, Nguyet Tu Tran","doi":"10.1093/jphsr/rmae004","DOIUrl":"https://doi.org/10.1093/jphsr/rmae004","url":null,"abstract":"\u0000 \u0000 \u0000 In many countries, self-medication is, in fact, the main service provided, exhausting pharmacist time and increasing their workload. However, there are currently no reports describing the impact of burnout on patient medication counseling.\u0000 \u0000 \u0000 \u0000 This study was conducted to determine the influence of burnout on over-the-counter (OTC) medication counseling services in Vietnam.\u0000 \u0000 \u0000 \u0000 A cross-sectional study was conducted in community pharmacies across four districts in Can Tho City, Vietnam, between April and May 2023. Burnout was assessed using the Maslach Burnout Inventory-Human Services Survey (MBI-HSS), comprising three subscales: emotional exhaustion (EE; 9 items), depersonalization (DP; 5 items), and personal accomplishment (PA; 8 items). OTC medication counseling activities were evaluated using 12 questions.\u0000 \u0000 \u0000 \u0000 Of the 385 participants recruited, 22.3% reported high work intensity as a common factor contributing to burnout. Pharmacists with burnout had significantly lower medication counseling scores than those without burnout (mean = 4.35 vs. mean = 4.55, P = 0.005). Of the 12 OTC medication counseling activities, 6 activities, including inquiring about the recent medications used by the patient (P = 0.044), discouraging long-term medication use (P = 0.021), warning about the possibility of self-misdiagnosis (P < 0.001), warning about the possibility of the patient choosing the wrong treatment method (P = 0.001), providing advice on improving health (P = 0.005), and inquiring about allergies in the patient (P < 0.001), had significantly lower scores in pharmacists with burnout.\u0000 \u0000 \u0000 \u0000 There was a significant negative association between burnout and medication counseling activities. Increasing staff numbers may be a useful solution for reducing work intensity, as this factor is reported to contribute the most to burnout among current pharmacists.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140254230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}